The Deal Room: Big Pharma M&A Splurge & Kim Kardashian's Private Equity Fund
Market Maker
00:00
The $85 Billion Patent Cliff Edge
Pfizer's revenue fell from 68 to 59 billion, still a lot of money, but that's a big form in two years due to this patent cliff edge. The statin Lipitor wants the world's most lucrative drug, sales dropped from 11 billion to 4 billion, free and post exclusivity. There's a combination of going, all right, there's a patent cliff Edge. We need blockbuster drugs that have still got 10 or 15 years of life left on the shelf. Plus, we want to start investing in and acquiring more nimble biotechs where their pipeline, maybe 10, 15, 20 years out is looking quite attractive.
Play episode from 07:14
Transcript
